| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 615.76B | 615.82B | 605.42B | 584.31B | 558.40B |
| Gross Profit | 104.36B | 101.50B | 98.28B | 87.19B | 89.44B |
| EBITDA | 35.87B | 36.31B | 45.96B | 30.65B | 34.67B |
| Net Income | 32.90B | 13.90B | 19.43B | 9.13B | 12.07B |
Balance Sheet | |||||
| Total Assets | 426.82B | 431.07B | 431.22B | 410.13B | 401.89B |
| Cash, Cash Equivalents and Short-Term Investments | 14.04B | 21.37B | 29.00B | 20.35B | 19.99B |
| Total Debt | 46.31B | 55.86B | 58.87B | 69.88B | 72.23B |
| Total Liabilities | 186.07B | 183.03B | 195.92B | 194.22B | 192.36B |
| Stockholders Equity | 237.67B | 244.68B | 232.09B | 212.88B | 206.78B |
Cash Flow | |||||
| Free Cash Flow | -4.39B | 167.00M | 11.88B | 7.04B | 9.45B |
| Operating Cash Flow | 22.90B | 21.10B | 30.46B | 26.81B | 29.42B |
| Investing Cash Flow | 7.17B | -18.51B | -6.31B | -19.62B | -20.21B |
| Financing Cash Flow | -37.46B | -10.38B | -15.64B | -7.29B | -11.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥211.96B | 6.51 | ― | 2.47% | >-0.01% | 155.92% | |
65 Neutral | ¥341.87B | 54.26 | 1.86% | 1.64% | 12.09% | 13.34% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥423.79B | 15.66 | ― | 2.42% | 1.83% | 340.84% | |
60 Neutral | ¥163.81B | 6.07 | 12.56% | 3.44% | 4.40% | 91.05% | |
59 Neutral | ¥1.01T | 28.37 | 5.97% | 2.96% | 1.70% | -30.43% | |
53 Neutral | ¥314.79B | 28.25 | ― | 1.45% | 15.06% | 399.49% |